Drug intelligence / Profile preview

2-[(cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

Development stage
Preclinical
Modality
Small Molecules
01

Overview

A synthetic small molecule compound belonging to the thiophene carboxamide class. It is primarily known as an experimental inhibitor of serine/threonine-protein kinase PknG (PKNG_MYCTU), a bacterial kinase implicated in the survival and virulence of Mycobacterium tuberculosis. By inhibiting PknG activity in M. tuberculosis and related mycobacteria species such as M. bovis BCG and M. smegmatis (Msmeg), this compound disrupts bacterial signaling pathways that allow intracellular persistence within host macrophages[5]. The molecule has been studied for its potential as an anti-mycobacterial agent but is not approved for clinical use[3][10].

Other names
2-cyclopropaneamido-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide2-(cyclopropanecarbonylamino)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide2-(cyclopropanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamideBenzo[b]thiophene-3-carboxamide, 2-[ (cyclopropylcarbonyl)amino ] -4,5,6,7-tetrahydro-
02

Targets

PknG (Serine/threonine-protein kinase PknG)

Beyond the preview

Go deeper on 2-[(cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2-[(cyclopropylcarbonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call